Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: Implications for monitoring of minimal residual disease

British Journal of Haematology

Volumn 110, Issue 1, 2000, Pages 139-146

  Van Wering, Elisabeth R ^a,e   Van Der Linden Schrever, Birgit E M ^a   Szczepanski, Tomasz ^b,c   Willemse, Marja J ^b   Baars, Ed A ^a   Van Wijngaarde Schmitz, Hanne M ^a   Kamps, Willem A ^a,d   Van Dongen, Jacques J M ^b  

^a Dutch Childhood Leukemia Study Group   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

^e Dutch Childhood Leukaemia Stud Grp   (Netherlands)

Author keywords

ALL; B cell precursors; Immunophenotyping; Minimal residual disease; Regenerating bone marrow

Indexed keywords

CD19 ANTIGEN; CD34 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; HETERODUPLEX; LYMPHOCYTE ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; B LYMPHOCYTE; CANCER EPIDEMIOLOGY; CELL REGENERATION; CELL STRUCTURE; CHILD; GENE REARRANGEMENT; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; IMMUNOPHENOTYPING; INFANT; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; MONITORING; NEWBORN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROLYMPHOCYTE;

ADOLESCENT; B-LYMPHOCYTES; CELL DIVISION; CHILD; CHILD, PRESCHOOL; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; REMISSION INDUCTION;

EID: 0033900075     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02143.x     Document Type: Article

References (41)

1. Detection of immunoglobulin heavy-chain gene rearrangements by Southern blot analysis: Recommendations for optimal results
2. Immunologic rebound after cessation of long-term chemotherapy in acute leukemia
3. Age-related changes of immunophenotypically immature lymphocytes in normal human peripheral blood
4. B-cell precursors in normal pediatric bone marrow
5. Detection of minimal residual disease in acute leukemia: By flow cytometry
6. Profound abnormality of the B/T lymphocyte ratio during chemotherapy for pediatric acute lymphoblastic leukemia
7. Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALL
8. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia
9. Expansion of polyclonal B-cell precursors in bone marrow from children treated for acute lymphoblastic leukemia
10. Multiparameter phenotype mapping of normal and post-chemotherapy B lymphopoiesis in pediatric bone marrow
11. Four-color flow cytometric investigation of terminal deoxynucleotidyl transferase-positive lymphoid precursors in pediatric bone marrow: CD79a expression precedes CD19 in early B-cell ontogeny
12. Comparative phenotype mapping of normal vs. malignant pediatric B-lymphopoiesis unveils leukemia-associated aberrations
13. Quantitative flow cytometry can distinguish between normal and leukaemic B-cell precursors
14. Multicolor flow-cytometric, morphologic, and clonogenic analysis of marrow CD10-positive cells in children with leukemia in remission or nonmalignant diseases
15. Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts
16. Leukaemia-associated immunophenotypes (LAIP) are observed on 90% of adult and childhood acute lymphoblastic leukaemia: Detection in remission marrow predicts outcome
17. Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells
18. Terminal transferase-positive human bone marrow cells exhibit the antigenic phenotype of common acute lymphoblastic leukemia
19. Characterization of normal and regenerating bone marrow cells with a panel of monoclonal antibodies
20. Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations
21. Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development
22. Hematogones: A multiparameter analysis of bone marrow precursor cells
23. Flow cytometric analysis of normal B cell differentiation: A frame of reference for the detection of minimal residual disease in precursor-B-ALL
24. Terminal deoxynucleotidyl transferase (TdT)-positive cells in bone marrow in the absence of hematologic malignancy
25. Primers and protocols for standardized MRD detection in ALL using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets. Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia
26. Age-related changes of lymphocyte subsets in normal bone marrow biopsies
27. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86
28. Improved detection of rare CALLA-positive cells in peripheral blood using multiparameter flow cytometry
29. Regeneration of CALLA (CD10+), TdT+ and double-positive cells in the bone marrow and blood after autologous bone marrow transplantation
30. Immunodeficiency in long-term survivors of acute lymphoblastic leukemia treated with Berlin-Frankfurt-Munster therapy
31. The KOR-SA3544 antigen predominantly expressed on the surface of Philadelphia chromosome-positive acute lymphoblastic leukemia cells is nonspecific cross-reacting antigen-50/90 (CD66c) and invariably expressed in cytoplasm of human leukemia cells
32. Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: Implications for selection of PCR targets for detection of minimal residual disease
33. Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in compl V-D-J rearrangements, and are rare in T-cell receptor αβ lineage
34. Cross-lineage T-cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B-acute lymphoblastic leukemias: Alternative PCR targets for detection of minimal residual disease
35. Immunological phenotype of lymphoid cells in regenerating bone marrow of children after treatment for acute lymphoblastic leukemia
36. Analysis of immunoglobulin and T cell receptor genes. Part I. Basic and technical aspects
37. Immunological marker analysis of cells in the various hematopoietic differentiation stages and their malignant counterparts
38. Detection of minimal residual disease in acute leukemia patients
39. Triple immunofluorescence staining for prediction of relapse in childhood precursor B acute lymphoblastic leukaemia
40. A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: Implications for residual disease detection
41. Multidimensional flow cytometry of marrow can differentiate leukemic from normal lymphoblasts and myeloblasts after chemotherapy and bone marrow transplantation